Posts Tagged 'androgel'

AndroGel Retrial Leads to Award and Another Finding of Negligence

androgel retrial leads to finding of negligenceWhen an AndroGel lawsuit brought against pharmaceutical manufacturer AbbVie resulted in a $150 million award for the Oregon resident who filed it, the legal world took notice. The award was unique not only for the amount, but also in the way the amount was distributed.

A Chicago jury awarded plaintiff Jesse Mitchell nothing in compensation for the injuries or medical costs he incurred after a heart attack he attributed to ...

continue reading...

Bellwether AndroGel Lawsuit Ends in Drugmaker Win

AndroGel maker takes win in bellwether testosterone therapy lawsuit trialAn Arizona man was unsuccessful in his attempt to find AndroGel manufacturer AbbVie responsible for a pulmonary embolism he suffered two months after starting testosterone replacement therapy. The lawsuit, filed in 2014 and decided just recently, claimed that AbbVie misled the public by focusing most of its television advertising on off-label uses for the drug.

Testosterone therapy and replacement commercials have taken the airwaves ...

continue reading...

First Testim Trial Ends with Decision in Favor of Drugmaker

testim trial sides with drugmakerTestim maker Endo International’s Auxilium unit emerged victorious in the first trial over whether its testosterone therapy drug caused a heart attack in a patient.

The Tennessee plaintiff had been prescribed Testim for what he described as chronic fatigue and had been applying the testosterone gel to himself for over 6 months. In July 2014, he suffered a heart attack and was subsequently hospitalized twice. His recovery since then has ...

continue reading...

Androgel Maker Faces Another Big Verdict

androgel faces 150 million dollar verdict in low-t trialYet again, a jury sent AbbVie, maker of the popular prescription testosterone drug Androgel, a loud and clear message. A federal jury in Chicago found that AbbVie misrepresented the dangers of using Androgel. And to make sure the drugmaker got their message, it also reached a verdict in excess of $140 million.

This most recent trial is the second bellwether case to be tried in the federal testosterone replacement therapy ...

continue reading...

Androgel Maker Ordered to Pay Up With $150 Million Verdict

Androgel maker loses case for $150 million verdictOne would think that a verdict of this magnitude would send a very loud, very clear message to Androgel maker AbbVie. Unfortunately, the testosterone therapy maker may actually escape paying on this verdict, calling into question whether the company will still “hear” the jury.

The $150 million testosterone verdict was just issued in the case of an Oregon man whose lawsuit accused AbbVie of hiding the risk of ...

continue reading...

FDA Warns of Potential for Testosterone Abuse

fda warning on testosterone abuseAs we’ve seen with the opioid epidemic sweeping across the country, the more available a prescription drug becomes, the greater the potential seems to become for that prescription drug to be abused. As drug companies flood American cities and towns with more painkillers than they could possibly take under normally-prescribed conditions, the number of overdoses and deaths has skyrocketed.

Sadly, that same kind of dependency and abuse is now starting to show itself ...

continue reading...
Page 1 of 3 123